Deflazacort Tablets

Dorfaza 6

Introduction

KureKraft Pharmaceuticals proudly presents Dorfaza 6 Tablet, a clinically trusted formulation of Deflazacort, specifically designed for the effective management of Duchenne Muscular Dystrophy (DMD). This advanced corticosteroid therapy plays a vital role in reducing inflammation, preserving muscle strength, and slowing disease progression in patients suffering from this genetic condition.

In today’s evolving healthcare environment, neuromuscular disorders such as DMD require long-term, reliable, and well-tolerated treatment options. Dorfaza 6 Tablet emerges as a powerful solution that supports improved mobility, enhances quality of life, and provides sustained therapeutic benefits when used under medical supervision.

With its targeted mechanism of action and proven clinical outcomes, Deflazacort has become a preferred corticosteroid in managing chronic inflammatory and muscular conditions, making Dorfaza 6 a dependable choice for both healthcare providers and patients.

Comprehensive Guide to Deflazacort Tablets (Dorfaza 6)

What is Dorfaza 6 Tablet?

Dorfaza 6 Tablet is a corticosteroid medication containing Deflazacort 6 mg, primarily indicated for the treatment of Duchenne Muscular Dystrophy (DMD). It belongs to a class of drugs that help reduce inflammation and modify immune system responses.

This medication is widely used due to its effective anti-inflammatory properties and comparatively favorable safety profile among corticosteroids.

How Deflazacort Works Effectively

Mechanism of Action of Deflazacort

Deflazacort works by:

Inhibiting inflammatory mediators that cause muscle damage
Suppressing immune system overactivity
Reducing swelling and tissue destruction
Stabilizing muscle cell membranes
Improving muscle function and strength over time

Therapeutic Impact

Through its action, Dorfaza 6 Tablet helps:

Slow down muscle degeneration
Preserve mobility and physical function
Enhance daily activity performance
Reduce disease-related complications

Common Condition Managed

Duchenne Muscular Dystrophy (DMD)

Dorfaza 6 Tablet is primarily prescribed for:

A genetic disorder causing progressive muscle weakness
Difficulty in walking, climbing stairs, and lifting objects
Gradual loss of muscle strength over time

Symptoms Managed by Dorfaza 6 Tablet

Patients using Deflazacort Tablets may experience relief from:

Progressive muscle weakness
Difficulty in movement
Loss of muscle coordination
Reduced stamina and endurance
Muscle inflammation and damage

Composition of Dorfaza 6 Tablet

Product Specifications

Brand Name: Dorfaza 6
Generic Name: Deflazacort
Strength: 6 mg
Dosage Form: Tablet
Packaging Size: 10×10 Tablets
Packaging Type: Blister Pack
Shelf Life: 24 Months
Prescription Status: Prescription Only
Usage: Duchenne Muscular Dystrophy Treatment
Country of Origin: Made in India
Manufacturer: KureKraft Pharmaceuticals
Business Type: PCD Pharma Franchise & Third Party Manufacturing

Active Ingredient and Its Role

Deflazacort

Deflazacort is a glucocorticoid that:

Reduces inflammation and immune response
Prevents muscle damage progression
Helps maintain muscle strength
Improves overall functional ability
Offers a better tolerability profile compared to traditional steroids

Uses of Dorfaza 6 Tablet

Primary Use

Duchenne Muscular Dystrophy (DMD) management

Secondary Uses (as prescribed)

Chronic inflammatory conditions
Autoimmune disorders
Allergic conditions
Muscular and connective tissue diseases

Medical Benefits of Deflazacort Tablets

Slows Disease Progression

Reduces rate of muscle degeneration
Maintains mobility for a longer duration

Preserves Muscle Strength

Supports muscle function
Enhances physical performance

Improves Quality of Life

Enables better daily activity
Reduces disability progression

Anti-inflammatory Action

Minimizes swelling and tissue damage
Controls chronic inflammation

Immune System Regulation

Prevents harmful immune responses
Supports long-term disease management

How Dorfaza 6 Tablet Works

Pharmacological Action

The therapeutic effectiveness of Deflazacort includes:

Blocking release of inflammatory chemicals
Reducing immune-mediated tissue damage
Stabilizing cell membranes
Enhancing muscle preservation mechanisms

Clinical Outcome

Patients may experience:

Improved muscle strength
Reduced fatigue
Better mobility
Slower disease progression

Dosage and Administration

Take as prescribed by a healthcare professional
Can be taken with or without food
Maintain consistent timing for best results
Do not stop abruptly without medical advice

Common Side Effects

While Dorfaza 6 Tablet is generally well-tolerated, some patients may experience:

Increased appetite
Weight gain
Frequent urination
Cushing syndrome symptoms
Upper respiratory infections
Cough
Abnormal hair growth
Nasopharyngitis
Obesity

When to Seek Medical Advice

Persistent or severe side effects
Signs of infection (fever, sore throat)
Allergic reactions

Important Precautions

Infections

Avoid exposure to infections
Inform doctor if symptoms appear

Pregnancy

Use only under medical supervision

Breastfeeding

Consult a doctor before use

Existing Medical Conditions

Inform about liver, kidney, or immune disorders

Drug Interactions

Disclose all medications being taken

What If You Miss a Dose?

Take the missed dose as soon as remembered
Skip if close to next dose
Avoid double dosing

Storage Instructions

Store in a cool and dry place
Protect from direct sunlight
Keep away from moisture
Keep out of reach of children

Proper storage ensures:

Drug stability
Safety
Maximum effectiveness

Third Party Manufacturing & PCD Pharma Franchise

KureKraft Pharmaceuticals Services

Third Party Manufacturing

Advanced manufacturing facilities
Strict quality control standards
Custom formulation services
Timely product delivery

PCD Pharma Franchise Opportunities

Monopoly rights
Strong marketing support
Wide product portfolio
High return on investment

Why Choose Dorfaza 6 by KureKraft Pharmaceuticals?

Clinically proven Deflazacort formulation
High-quality manufacturing standards
Reliable and consistent therapeutic results
Trusted by healthcare professionals
Affordable and accessible treatment option

Conclusion

Dorfaza 6 Tablet (Deflazacort) by KureKraft Pharmaceuticals stands as a highly effective and reliable treatment for Duchenne Muscular Dystrophy. Its advanced corticosteroid action helps reduce inflammation, preserve muscle strength, and significantly slow the progression of muscle weakness.

With its strong clinical performance, improved tolerability, and long-term therapeutic benefits, Dorfaza 6 provides a comprehensive solution for managing one of the most challenging neuromuscular disorders. It empowers patients to maintain mobility, enhance daily functioning, and achieve a better quality of life.

For safe, effective, and trusted management of DMD, Dorfaza 6 Tablet remains a leading choice backed by pharmaceutical excellence.